Wide Array of Services in Multiple Myeloma

Brochure Jun 21, 2021

Oncologie

June 21, 2021

DOWNLOAD OUR INFOGRAPHIC

Poster: analytical validation of high-resolution ctDNA profiling with TSO500 v2.0.

Affiches

Apr 20, 2026

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

Affiches

Mar 3, 2026

Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)

Affiches

Mar 3, 2026

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Wide Array of Services in Multiple Myeloma

Featured Resources

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

One global CRO for your whole therapeutic development journey